Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Interaction Between Spasticity and the Initial Response After Balance Perturbations in Children With Spastic Cerebral Palsy

22 mai 2026 mis à jour par: Kaat Desloovere, Universitaire Ziekenhuizen KU Leuven

Association Between the Initial Response After Perturbation to Standing Balance and Spasticity Measurements (1) and Kinematic Response Strategy to Restore Balance (2) in Children With Spastic Cerebral Palsy

The aim of this study was to investigate the link between spasticity and the initial response after standing balance perturbations in children with spastic cerebral palsy. Reactive balance performance was tested using a moving platform. The investigators provided two types of perturbations, (1) backward translations and (2) rotations towards dorsiflexion, of different magnitudes. Spasticity was assessed using instrumented clinical tests of spasticity as the pendulum test and isolated passive joint rotations. Kinematics and EMG were measured simultaneously.

Aperçu de l'étude

Description détaillée

Background:

Spasticity is a common impairment following an upper motor neuron lesion, such as cerebral palsy (CP). Children with CP suffer a lot from balance impairments, which will impair their participation in daily life activities. When clinically assessing spasticity, a passive muscle is stretched and spasticity is scored based on the observed resistance against this stretch. Similar muscle stretches also occur when standing balance is perturbed, as for example when standing on a departing bus or walking on uneven terrain.

Maintaining balance involves complex sensorimotor transformations to activate the muscle to produce the required balance correcting response. Sensorimotor processing refers to how the nervous system translates incoming sensory information about body motion into motor commands to activate muscles. In both healthy animals and humans, sensorimotor processes underlying reactive standing balance can be explained by delayed feedback from CoM kinematics. The sensitivity to the CoM disturbance have been shown to be relatively constant within one subject, but change with age, age-related cognitive decline, sensory deficits, and neurological impairments.

Both kinematic and muscle responses to perturbations of standing balance are impaired in children with CP. Children with CP have a higher chance of losing their balance, change to a stepping strategy at lower perturbation levels, and have increased muscle (co-)activation. However, it is unknown whether the underlying sensorimotor transformations are altered in CP and how these changes contribute to the altered balance responses observed in CP. Therefore, the first aim was to understand alterations in sensorimotor processing underlying reactive standing balance control in children with spastic CP.

The increased muscle co-activation that is observed in CP might be a functional compensation strategy to improve balance control. For example, muscle co-activation will increase joint stiffness and therefore resisting movement of the body with respect to the feet during backward translational perturbations. In this case, co-activation will help to maintain balance. However, it is not clear whether children with CP use the increased co-activation as compensation strategy to improve balance control or whether the muscle co-activation is a consequence of impaired balance control. When standing balance is perturbed using rotational perturbations, muscle co-activation will hinder balance control. Increased muscle co-activation and the following increased joint stiffness will couple body movement to platform movement resulting in body tilt. Hence, increasing joint stiffness might not be beneficial during rotational perturbations. Our second aim was to investigate whether children with CP use increased muscle co-activation as a compensation strategy to improve balance control or whether muscle co-activation causes balance control impairments by combining translational and rotational perturbations of standing balance.

Muscle stretches occur during isolated joint rotations, as clinically applied when assessing joint hyper-resistance, and during perturbations of standing balance. Children with CP respond to both isolated joint rotations and perturbations of standing with increased excitation of the stretched muscle, combined with increased agonist-antagonist co-activation. Although the striking similarities between both reactive muscle responses to muscle stretches, little is known about the relation between joint hyper-resistance and reactive balance. Therefore our third aim was to explore the relation between muscle responses to instrumented tests of joint hyper-resistance and translational and rotational perturbations of standing balance.

Methods:

Twenty children with CP and twenty age-matched typically developing (TD) children participated in this study. Children with CP were diagnosed by a neuro-pediatrician and met the following inclusion criteria: (1)aged between 5 and 17 years old; (32) Gross Motor Classification Scale I-III; (3) able to stand independently for at least 10 minutes; (4) no orthopedic/neurological surgery in the previous year; and (5) no botulinum neurotoxin injections in the previous six months.

An instrumented spasticity assessment (hereafter called isolated joint rotations) using the method described by Bar-On and colleagues was performed. Participants lay supine and were asked to relax. The lower leg was supported by a customized frame that allowed ankle rotation. A researcher applied five times a passive rotation of the ankle joint, as fast as possible from a plantar flexed position to the end range of motion towards dorsiflexion.

Reactive balance was tested on a Caren platform. Participants stood barefoot on the platform and were secured with a safety harness. Instructions were to stand upright and maintain balance without stepping unless stepping was necessary to avoid failing. The protocol consisted of six increasingly difficult perturbations levels for the backward translations and four increasingly difficult perturbation levels for the toe-up rotational perturbations. Withing each level, eight perturbations were administered. When participants stepped I more than 3 trials within a level, the participant did not continue to the next level.

Trajectories of reflective skin markers were captured by infrared Vicon Cameras and activity of the lower leg muscles (lateral gastrocnemius, medial gastrocnemius, soleus and tibialis anterior) was measured simultaneously through surface electromyography.

Type d'étude

Observationnel

Inscription (Réel)

40

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Vlaams-Brabant
      • Leuven, Vlaams-Brabant, Belgique, 3000
        • UZ Leuven

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Enfant

Accepte les volontaires sains

Oui

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

Children with spastic cerebral palsy, who have routine follow-up care at the CP reference center of the university hospitals Leuven.

Typically developing children are recruited through the social and professional network of involved researchers and thesis studies, who approach participants through flyers and social media.

La description

Children with CP:

Inclusion Criteria:

  • Diagnosis of cerebral palsy
  • Spasticity as defined by clinical assessment
  • Aged between 5-17 years old
  • Gross motor classification scale I-III
  • Able to stand independently for at least 10 minutes

Exclusion Criteria:

  • Orthopedic/neurological surgery in the previous year
  • Botulinum neurotoxin injections in the past 6 months
  • Presence of ataxia or dystonia
  • Cognitive problems that impede measurements
  • Severe co-morbidities

Typically developing children:

Inclusion criteria:

  • Aged between 5 and 17 years old
  • Good health

Exclusion criteria:

  • Presence of neuro-musculoskeletal or vestibular diseases
  • Lower limb injuries during the past 6 months
  • Irritated skin or open wounds where sensors will be placed (CP en TD)

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Cohortes et interventions

Groupe / Cohorte
Children with cerebral palsy
Children with CP aged between 5 and 17
Typically developing children
Typically developing children aged between 5 and 17

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Balance performance
Délai: Cross-sectional data collection at a single time point (baseline measurement).
The number (#) of completed perturbation levels (backward translational and toe-up rotational) without stepping.
Cross-sectional data collection at a single time point (baseline measurement).
Maximal horizontal center of mass displacement
Délai: Cross-sectional data collection at a single time point (baseline measurement).

The maximal horizontal Center of Mass (CoM) displacement (cm) is computed in a period of 1.5s following perturbation onset.

CoM position is computed by consequently applying OpenSim's Inverse Kinematics and Body Kinematics tools with reflective marker trajectories as input. CoM displacement was calculated relative to the ankle.

Cross-sectional data collection at a single time point (baseline measurement).
Goodness of fit between predicted and reconstructed muscles activity - R²
Délai: Cross-sectional data collection at a single time point (baseline measurement)

Computational model; Sensorimotor transformations were evaluated by reconstructing measured EMG trajectories (V) by delayed feedback from CoM kinematics.

EMGrecon=e0+⌊kd∗dCoM(t -τ)+kv∗vCoM(t -τ)+ka∗aCoM(t -τ)+ks

∗aCoM Init(t -τ)⌋ with EMG recon = reconstructed muscle activity E0 = baseline muscle activity (during quiet standing) dCoM, vCoM, aCoM = CoM displacement, velocity and acceleration kd, kv, ka = feedbakc gains or weights τ = common time delay of 100 ms

To test whether CoM feedback can explain reactive muscle activity, the goodness of fit was assessed between predicted and reconstructed muscle activity using the coefficient of determination (r²).

R² was calculated as the squared correlation coefficient.

Cross-sectional data collection at a single time point (baseline measurement)
Goodness of fit between predicted and reconstructed muscles activity - VAF
Délai: Cross-sectional data collection at a single time point (baseline measurement)

Computational model; Sensorimotor transformations were evaluated by reconstructing measured EMG trajectories (V) by delayed feedback from CoM kinematics.

EMGrecon=e0+⌊kd∗dCoM(t -τ)+kv∗vCoM(t -τ)+ka∗aCoM(t -τ)+ks

∗aCoM Init(t -τ)⌋ with EMG recon = reconstructed muscle activity E0 = baseline muscle activity (during quiet standing) dCoM, vCoM, aCoM = CoM displacement, velocity and acceleration kd, kv, ka = feedbakc gains or weights τ = common time delay of 100 ms

To test whether CoM feedback can explain reactive muscle activity, the goodness of fit was assessed between predicted and reconstructed muscle activity using the Variance Accounted For (VAF).

VAF was calculated as the uncentered r²

Cross-sectional data collection at a single time point (baseline measurement)
Goodness of fit between predicted and reconstructed muscles activity - RMSE
Délai: Cross-sectional data collection at a single time point (baseline measurement)

Computational model; Sensorimotor transformations were evaluated by reconstructing measured EMG trajectories (V) by delayed feedback from CoM kinematics.

EMGrecon=e0+⌊kd∗dCoM(t -τ)+kv∗vCoM(t -τ)+ka∗aCoM(t -τ)+ks

∗aCoM Init(t -τ)⌋ with EMG recon = reconstructed muscle activity E0 = baseline muscle activity (during quiet standing) dCoM, vCoM, aCoM = CoM displacement, velocity and acceleration kd, kv, ka = feedbakc gains or weights τ = common time delay of 100 ms

To test whether CoM feedback can explain reactive muscle activity, the goodness of fit was assessed between predicted and reconstructed muscle activity using the Root Mean Square Error (RMSE).

Cross-sectional data collection at a single time point (baseline measurement)
Sensitiviy of reactive muscle activity to CoM perturbations - gains
Délai: Cross-sectional data collection at a single time point (baseline measurement)

Computational model; Sensorimotor transformations were evaluated by reconstructing measured EMG trajectories (V) by delayed feedback from CoM kinematics.

EMGrecon=e0+⌊kd∗dCoM(t -τ)+kv∗vCoM(t -τ)+ka∗aCoM(t -τ)+ks

∗aCoM Init(t -τ)⌋ with EMG recon = reconstructed muscle activity E0 = baseline muscle activity (during quiet standing) dCoM, vCoM, aCoM = CoM displacement, velocity and acceleration kd, kv, ka = feedbakc gains or weights τ = common time delay of 100 ms

To test the sensitivity of the reactive muscle activity to the CoM perurbations, the gains (kd,kv,ka) were assessed. Gains indicate the sensitivity of the muscle response to CoM perturbations.

Cross-sectional data collection at a single time point (baseline measurement)
Mean reactive muscle activity
Délai: Cross-sectional data collection at a single time point (baseline measurement).

Average reactive muscle activity for

  • lateral gastrocnemius
  • medial gastrocnemius
  • soleus
  • tibialis anterior was computed in three time bins. Reactive muscle activity was calculated by subtracting baseline activity, i.e. average muscle activity in the 100 ms preceding perturbation onset, from the filtered and scaled EMG.

The first time bin lasted from platform onset to 150 ms after perturbation onset.

The second time bin lasted from 150 ms to 250 ms after perturbation onset. The third time bin lasted from 250 ms to 400 ms after perturbation onset.

Cross-sectional data collection at a single time point (baseline measurement).
Mean center of mass movement
Délai: Cross-sectional data collection at a single time point (baseline measurement).

Average horizontal center of mass movement (cm) was computed in three time bins.

The first time bin lasted from platform onset to 50 ms after perturbation onset.

The second time bin lasted from 50 ms to 150 ms after perturbation onset. The third time bin lasted from 150 ms to 300 ms after perturbation onset.

Cross-sectional data collection at a single time point (baseline measurement).
Mean ankle kinematics
Délai: Cross-sectional data collection at a single time point (baseline measurement).

Average ankle kinematics (°) was computed in three time bins.

The first time bin lasted from platform onset to 50 ms after perturbation onset.

The second time bin lasted from 50 ms to 150 ms after perturbation onset. The third time bin lasted from 150 ms to 300 ms after perturbation onset.

Cross-sectional data collection at a single time point (baseline measurement).
Co-Contraction Index (CCI) during translational and rotational perturbations and during isolated joint rotations
Délai: Cross-sectional data collection at a single time point (baseline measurement).

The co-contraction index was calculated as the minimum tibialis anterior and respectively lateral gastrocnemius, medial gastrocnemius and soleus filtered and scaled EMG averaged over the time interval of interest.

CCI was calculated during backward translational, toe-up rotational perturbations and during isolated joint rotations.

Cross-sectional data collection at a single time point (baseline measurement).

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Collaborateurs

Les enquêteurs

  • Chercheur principal: Kaat Desloovere, Prof. dr., Department of Rehabilitation Sciences, KU Leuven, Belgium

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

13 mars 2020

Achèvement primaire (Réel)

30 août 2021

Achèvement de l'étude (Réel)

30 août 2021

Dates d'inscription aux études

Première soumission

8 mai 2026

Première soumission répondant aux critères de contrôle qualité

22 mai 2026

Première publication (Réel)

1 juin 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

1 juin 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

22 mai 2026

Dernière vérification

1 avril 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

INDÉCIS

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner